Marex Group officer proposes $4.82M share sale
The proposed sale is connected to a plan dated October 22, 2025, intended to comply with Rule 10b5-1(c).
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Marex Group Ltd (MRX) officer Paolo Roberto Tonucci gave notice of a proposed sale of 66,666 common shares, with an indicated aggregate market value of $4,819,285.14. The securities information lists October 12, 2026, as the approximate sale date; the notice is dated October 13, 2026.
The shares were acquired from the issuer in a private transaction on December 31, 2019. The listed sales are in connection with a selling plan dated October 22, 2025, intended to comply with Rule 10b5-1(c). Tonucci also reported sales of 16,668 shares on August 10, 2026, 16,666 shares on July 13, 2026, and 16,666 shares on September 14, 2026.
Key Figures
Key Terms
Rule 10b5-1(c) regulatory
Rule 144 regulatory
private transaction financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What selling plan is connected to Paolo Roberto Tonucci's MRX sale?
AI-generated analysis. How Rhea-AI works. Not financial advice.